FR2585705B1 - Sels de cephalosporine et compositions injectables - Google Patents

Sels de cephalosporine et compositions injectables

Info

Publication number
FR2585705B1
FR2585705B1 FR8610892A FR8610892A FR2585705B1 FR 2585705 B1 FR2585705 B1 FR 2585705B1 FR 8610892 A FR8610892 A FR 8610892A FR 8610892 A FR8610892 A FR 8610892A FR 2585705 B1 FR2585705 B1 FR 2585705B1
Authority
FR
France
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8610892A
Other languages
English (en)
French (fr)
Other versions
FR2585705A1 (fr
Inventor
Murray A Kaplan
Thomas W Hudyma
Robert A Lipper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2585705A1 publication Critical patent/FR2585705A1/fr
Application granted granted Critical
Publication of FR2585705B1 publication Critical patent/FR2585705B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8610892A 1985-08-05 1986-07-28 Sels de cephalosporine et compositions injectables Expired FR2585705B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (2)

Publication Number Publication Date
FR2585705A1 FR2585705A1 (fr) 1987-02-06
FR2585705B1 true FR2585705B1 (fr) 1989-01-13

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8610892A Expired FR2585705B1 (fr) 1985-08-05 1986-07-28 Sels de cephalosporine et compositions injectables

Country Status (34)

Country Link
JP (1) JPH0615548B2 (sh)
KR (1) KR930003121B1 (sh)
AR (1) AR243894A1 (sh)
AT (1) AT390957B (sh)
AU (1) AU597262B2 (sh)
BE (1) BE905219A (sh)
CA (1) CA1284994C (sh)
CH (1) CH675581A5 (sh)
CS (2) CS276717B6 (sh)
CY (1) CY1614A (sh)
DD (2) DD254941A5 (sh)
DE (1) DE3626375A1 (sh)
DK (1) DK162053C (sh)
EG (1) EG18003A (sh)
ES (1) ES2002112A6 (sh)
FI (1) FI84484C (sh)
FR (1) FR2585705B1 (sh)
GB (1) GB2179936B (sh)
GR (1) GR862055B (sh)
HK (1) HK99691A (sh)
HU (1) HU196602B (sh)
IE (1) IE59222B1 (sh)
IL (1) IL79608A (sh)
IT (1) IT1197067B (sh)
LU (2) LU86540A1 (sh)
MY (1) MY102212A (sh)
NL (1) NL8601991A (sh)
OA (1) OA08672A (sh)
PT (1) PT83134B (sh)
SE (1) SE469633B (sh)
SG (1) SG79791G (sh)
SU (1) SU1516013A3 (sh)
YU (1) YU45793B (sh)
ZA (1) ZA865842B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
JP4616844B2 (ja) 2003-12-23 2011-01-19 サンド・ゲーエムベーハー セファロスポリン合成に使用するための中間体の生成プロセス
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
CY1614A (en) 1992-07-10
SG79791G (en) 1991-11-15
JPS62103090A (ja) 1987-05-13
FI863155A0 (fi) 1986-08-01
IT8621409A1 (it) 1988-02-04
FR2585705A1 (fr) 1987-02-06
PT83134A (en) 1986-09-01
AT390957B (de) 1990-07-25
HU196602B (en) 1988-12-28
CA1284994C (en) 1991-06-18
GB2179936B (en) 1989-04-26
DD268395A5 (de) 1989-05-31
AR243894A1 (es) 1993-09-30
LU88574I2 (fr) 1995-03-01
CS276849B6 (en) 1992-08-12
CS276717B6 (en) 1992-08-12
AU597262B2 (en) 1990-05-31
SE469633B (sv) 1993-08-09
DK371886A (da) 1987-02-06
DK371886D0 (da) 1986-08-04
SU1516013A3 (ru) 1989-10-15
DK162053B (da) 1991-09-09
ATA211086A (de) 1990-01-15
YU137186A (en) 1987-12-31
HK99691A (en) 1991-12-13
DE3626375A1 (de) 1987-02-12
HUT41802A (en) 1987-05-28
GB8618989D0 (en) 1986-09-17
IT1197067B (it) 1988-11-25
IE59222B1 (en) 1994-01-26
LU86540A1 (fr) 1987-03-06
BE905219A (fr) 1987-02-04
IE862078L (en) 1987-02-05
YU45793B (sh) 1992-07-20
FI863155A (fi) 1987-02-06
DD254941A5 (de) 1988-03-16
SE8603308D0 (sv) 1986-08-04
GR862055B (en) 1986-12-24
IL79608A0 (en) 1986-11-30
OA08672A (en) 1989-03-31
IT8621409A0 (it) 1986-08-04
DK162053C (da) 1992-02-10
NL8601991A (nl) 1987-03-02
ZA865842B (en) 1987-04-29
PT83134B (pt) 1989-07-31
FI84484C (fi) 1991-12-10
ES2002112A6 (es) 1988-07-16
EG18003A (en) 1991-08-30
FI84484B (fi) 1991-08-30
GB2179936A (en) 1987-03-18
AU6069486A (en) 1987-02-12
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
IL79608A (en) 1991-07-18
MY102212A (en) 1992-05-15
CH675581A5 (sh) 1990-10-15

Similar Documents

Publication Publication Date Title
DK106786D0 (da) Heterocycliske forbindelser
DK521589D0 (da) Cyclopropyl-substituerede dialkyl-forbindelser med insekticid virkning
DK179388A (da) Cephalosporinderivater
CY1663A (en) Cephalosporin salts and injectable compositions
FR2585705B1 (fr) Sels de cephalosporine et compositions injectables
DK219986D0 (da) Nitrogenholdige heterocycliske forbindelser
SE8500011L (sv) Cefalosporinantibiotika
DK496086A (da) Heterocykliske forbindelser
MC1729A1 (fr) Sels polycycliques
IT8548071A0 (it) Cefalosporina alogenidrato cristallino
DK500285A (da) Cephalosporinantibiotika
IT1200125B (it) Composti di cefalosporina e procedimento per produrli
DK166385D0 (da) Cephalosporinderivater samt salte deraf
DK397686D0 (da) Heterocycliske forbindelser
DK109586D0 (da) Heterocycliske forbindelser
DK414886A (da) Substituerede heterocycliske forbindelser
IL88959A (en) Cephalosporin salts and injectable compositions
DK577286D0 (da) Cephalosporinderivater
RO92098A2 (ro) Compozitie aditiva
LV5743A4 (lv) Heterocikliskie savienojumi
DK422085D0 (da) Heterocycliske forbindelser
DK280485D0 (da) Forskydeligt tremmegitter

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: CEFEPIME HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: NL 18323 19930727; FIRST REGISTRATION:

Spc suppl protection certif: 93C0068

Filing date: 19931223

CD Change of name or company name
CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: BO 44/94 PAGE 209:LIRE 2585705 AU LIEU DE 2586705

CP Supplementary protection certificate (spc) filed